GlassScriptPhysician profile
Neil A Burrell
NPI 1972509032
$774.11
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $104 · 2021: $240 · 2022: $169.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $240.93 | 2019-2022 | |
| Melinta Therapeutics, LLC | $142.78 | 2019-2022 | |
| Stryker Corporation | $113.55 | 2019 | |
| Paratek Pharmaceuticals, INC. | $66.98 | 2021-2022 | |
| Musculoskeletal Transplant Foundation INC. | $33.68 | 2021 | |
| Tactile Systems Technology INC | $26.58 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $23.32 | 2019 | |
| Janssen Pharmaceuticals, INC | $18.90 | 2022 | |
| Bioventus LLC | $18.43 | 2020 | |
| Organogenesis INC. | $18.21 | 2022 | |
| Zimmer Biomet Holdings, INC. | $17.08 | 2019 | |
| Treace Medical Concepts, INC. | $16.61 | 2022 | |
| Horizon Therapeutics Plc | $12.99 | 2019 | |
| Nabriva Therapeutics, Plc | $12.63 | 2021 | |
| Medela LLC | $11.44 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Burrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.